Open-label Study of the Effects of Montelukast in Patients With Chronic Cough
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Montelukast, a leukotriene receptor antagonist, is likely to be effective in the treatment of
chronic cough and this could be made objective by measuring cough threshold before and after
two weeks of treatment.